[PDF][PDF] Psychosis after buprenorphine, heroin, methadone, morphine, oxycodone, and tramadol withdrawal: a systematic review.

MT Lozano-López… - European Review for …, 2021 - europeanreview.org
Psychosis after buprenorphine, heroin, methadone, morphine, oxycodone, and tramadol
withdrawal: a systematic review Page 1 4554 Abstract. – OBJECTIVE: This study’s main …

[图书][B] Dual Disorder Heroin Addicts: Clinical and Therapeutical Aspects

I Maremmani, M Pacini, AGI Maremmani - 2023 - Springer
The study of aggression is crucial in psychiatry and psychopathology because hostile
behaviours are involved in various physical pathologies and because aggression has an …

[HTML][HTML] Comorbidities of Major Depressive Disorder and Bipolar Disorders in Patients with Substance Use Disorder in Iran Psychiatric Hospital: A Cross-sectional …

M Oladikalarijani, A Shabani, S Soraya… - Medical Journal of the …, 2023 - ncbi.nlm.nih.gov
Background Mood disorders are the most common psychiatric comorbidities in substance
users. Mood disorders and substance use disorders are 2 intertwined processes in which …

Hospitalizações por perturbação bipolar e perturbações do uso de substâncias: Um estudo nacional retrospetivo entre 2008 e 2015

LS da Silva Valente - 2024 - repositorio-aberto.up.pt
Background: Bipolar Disorder (BD) is a severe and chronic mental disorder often
complicated by co-occurring substance use disorders (SUD). This study aimed to assess the …

Mood Disorders in Dual Disorder Heroin Use Disorder Patients

I Maremmani, M Pacini, AGI Maremmani - Dual Disorder Heroin Addicts …, 2023 - Springer
An index episode of moderate depression characterized one patient out of three entering
methadone treatments, and surveys quote similar rates among large groups of subjects …

[PDF][PDF] Antagonist opioid medications in mental illness: State of art and future perspectives

I Maremmani, L Rovai, AGI Maremmani… - … Addiction Relat Clin …, 2015 - researchgate.net
Introduction: The involvement of the opioidergic system in the pathogenesis of various
addictive and non-addictive disorders has led to a renewed interest in expanding the clinical …

Heroin-induced chronic hypomania: a case report

S Prakash, YPS Balhara, S Deepak - Journal of Substance Use, 2016 - Taylor & Francis
The mood-altering effects of opioids are well known. Besides the short lasting alteration of
mood associated with acute effects of opioids, they are also known to induce psychiatric …

Evoking subclinical hypomania as a potential autism treatment-a hypothesis based on an up-to-date literature review

M Świerczek, K Nesterowicz - Medical Research Archives, 2018 - esmed.org
The growing number of children diagnosed with autism spectrum disorder (ASD) urges the
scientific community to find a simple and cost-effective solution to this problem. Before 1990 …

Withdrawal Emergent Recurrent Manic Episodes with Use of “Bhukki”: A Case Report

NK Nandan, LK Singh, SK Tikka… - Indian Journal of …, 2022 - journals.sagepub.com
Discussion Opioid agonists and antagonists have been studied for their psychomimetic
effects and mood-altering properties. Among the four receptors of the opioidergic system (ie …

Episodio maniaco con síntomas psicóticos tras desintoxicación de heroína: estudio de un caso

AN del Rosario - Psiquiatría Biológica, 2018 - Elsevier
El uso de fármacos agonistas opioides, como la metadona, en el tratamiento de la
dependencia a la heroína es altamente frecuente. A su vez, la prevalencia de trastornos …